Literature DB >> 28590513

Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome.

Filippo Ceccato1, Laura Trementino2, Mattia Barbot1, Giorgia Antonelli3, Mario Plebani3, Luca Denaro4, Daniela Regazzo1, Federico Rea5, Anna Chiara Frigo6, Carolina Concettoni2, Marco Boscaro1, Giorgio Arnaldi2, Carla Scaroni1.   

Abstract

BACKGROUND AND AIM: Differential diagnosis between Cushing's Disease (CD) and Ectopic ACTH Syndrome (EAS) may be a pitfall for endocrinologists. The increasing use in clinical practice of chromatography and mass spectrometry improves the measurement of urinary free cortisol (UFF) and cortisone (UFE). We have recently observed that cortisol to cortisone ratio (FEr) was higher in a small series of EAS; in this study we collected a larger number of ACTH-dependent Cushing's Syndrome (CS) to study the role of FEr to characterize the source of corticotropin secretion.
MATERIALS AND METHODS: High-pressure liquid chromatography with UV detection (HPLC-UV, n=35) or liquid chromatography-tandem mass spectrometry (LC-MS/MS, n=72) were used to measure UFF, UFE and FEr in 83 patients with CD and 24 with EAS.
RESULTS: UFF, UFE and FEr levels were higher in EAS than in CD (UFF: 6671 vs 549 nmol/24 hours; UFE: 2069 vs 464 nmol/24 hours; FEr: 4.13 vs 0.97; all P<.001). FEr >1.15 (the best ROC-based threshold) was able to distinguish CD from EAS with 75% sensitivity (SE) and 75% specificity (SP), AUC 0.811; results were similar between HPLC-UV (SE 73%, SP 79%, AUC 0.708) and LC-MS/MS (SE 77%, SP 73%, AUC 0.834; P=.727). The diagnostic accuracy of FEr was similar to that of CRH test or high-dose dexamethasone suppression test (respectively P=.171 and P=.683), also combined. Finally, FEr was able to increase the number of correct diagnosis in patients with discordant dynamic tests.
CONCLUSIONS: Urinary FEr >1.15 was able to suggest EAS, with a diagnostic accuracy similar to that of other dynamic tests proposed to study ACTH-dependent CS.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cushing's Disease; Ectopic ACTH Syndrome; cortisone; liquid chromatography-tandem mass spectrometry; urinary free cortisol

Mesh:

Substances:

Year:  2017        PMID: 28590513     DOI: 10.1111/cen.13391

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Nelson-Salassa Syndrome Progressing to Pituitary Carcinoma: A Case Report and Review of the Literature.

Authors:  Lucas P Carlstrom; Christopher S Graffeo; Avital Perry; Janalee K Stokken; Jamie J Van Gompel
Journal:  Cureus       Date:  2019-09-08

2.  Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case report.

Authors:  Huiwen Tan; Dawei Chen; Yerong Yu; Kai Yu; Weiming He; Bowen Cai; Su Jiang; Ying Tang; Nanwei Tong; Zhenmei An
Journal:  BMC Endocr Disord       Date:  2020-07-31       Impact factor: 2.763

3.  Improved salivary cortisol rhythm with dual-release hydrocortisone

Authors:  Filippo Ceccato; Elisa Selmin; Chiara Sabbadin; Miriam Dalla Costa; Giorgia Antonelli; Mario Plebani; Mattia Barbot; Corado Betterle; Marco Boscaro; Carla Scaroni
Journal:  Endocr Connect       Date:  2018-09-01       Impact factor: 3.335

Review 4.  Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?

Authors:  Gregori Casals; Felicia Alexandra Hanzu
Journal:  Ann Lab Med       Date:  2020-07       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.